These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 32870039)

  • 1. Physician attitudes on buprenorphine induction in the emergency department: results from a multistate survey.
    Zuckerman M; Kelly T; Heard K; Zosel A; Marlin M; Hoppe J
    Clin Toxicol (Phila); 2021 Apr; 59(4):279-285. PubMed ID: 32870039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initiation of Buprenorphine in the Emergency Department: A Survey of Emergency Clinicians.
    Barkley A; Lander L; Dilcher B; Tuscano M
    West J Emerg Med; 2024 Jul; 25(4):470-476. PubMed ID: 39028232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addressing System and Clinician Barriers to Emergency Department-initiated Buprenorphine: An Evaluation of Post-intervention Physician Outcomes.
    Mahal JJ; Bijur P; Sloma A; Starrels J; Lu T
    West J Emerg Med; 2024 May; 25(3):303-311. PubMed ID: 38801034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel social work approach to emergency department buprenorphine induction and warm hand-off to community providers.
    Kelly T; Hoppe JA; Zuckerman M; Khoshnoud A; Sholl B; Heard K
    Am J Emerg Med; 2020 Jun; 38(6):1286-1290. PubMed ID: 31959523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mixed-method comparison of physician-reported beliefs about and barriers to treatment with medications for opioid use disorder.
    Haffajee RL; Andraka-Christou B; Attermann J; Cupito A; Buche J; Beck AJ
    Subst Abuse Treat Prev Policy; 2020 Sep; 15(1):69. PubMed ID: 32928272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attitudinal barriers to buprenorphine prescription and former waiver training.
    Gannon MP; Tello M; Wakeman S; Charles JP; Lipsitz S; Samal L
    J Opioid Manag; 2024; 20(4):339-346. PubMed ID: 39321054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attitudes on Methadone Utilization in the Emergency Department: A Physician Cross-sectional Study.
    Heil J; Ganetsky VS; Salzman MS; Hunter K; Baston KE; Carroll G; Ketcham E; Haroz R
    West J Emerg Med; 2022 Apr; 23(3):386-395. PubMed ID: 35679506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interest in prescribing buprenorphine among resident and attending physicians at an urban teaching clinic.
    James JR; Gordon LM; Klein JW; Merrill JO; Tsui JI
    Subst Abus; 2019; 40(1):11-13. PubMed ID: 29578857
    [No Abstract]   [Full Text] [Related]  

  • 9. Barriers and attitudes reported by Canadian emergency physicians regarding the initiation of buprenorphine/naloxone in the emergency department for patients with opioid use disorder.
    Savage T; Ross M
    CJEM; 2022 Jan; 24(1):44-49. PubMed ID: 34564838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A qualitative assessment of emergency physicians' experiences with robust emergency department buprenorphine bridge programs.
    Heil JM; Lassiter JM; Salzman MS; Herring A; Hoppe J; Lynch M; Weiner SG; Roberts B; Haroz R
    Acad Emerg Med; 2024 Jun; 31(6):576-583. PubMed ID: 38357749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of an Education Module on the Knowledge and Attitudes of EM Physicians Towards Prescribing Buprenorphine/Naloxone for Opioid Use Disorder.
    Zosel A; Hernandez-Meier J; Owen J
    J Opioid Manag; 2024; 20(4):B13. PubMed ID: 39321067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Providing Incentive for Emergency Physician X-Waiver Training: An Evaluation of Program Success and Postintervention Buprenorphine Prescribing.
    Foster SD; Lee K; Edwards C; Pelullo AP; Khatri UG; Lowenstein M; Perrone J
    Ann Emerg Med; 2020 Aug; 76(2):206-214. PubMed ID: 32376089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation facilitation to promote emergency department-initiated buprenorphine for opioid use disorder: protocol for a hybrid type III effectiveness-implementation study (Project ED HEALTH).
    D'Onofrio G; Edelman EJ; Hawk KF; Pantalon MV; Chawarski MC; Owens PH; Martel SH; VanVeldhuisen P; Oden N; Murphy SM; Huntley K; O'Connor PG; Fiellin DA
    Implement Sci; 2019 May; 14(1):48. PubMed ID: 31064390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barriers and Facilitators to Clinician Readiness to Provide Emergency Department-Initiated Buprenorphine.
    Hawk KF; D'Onofrio G; Chawarski MC; O'Connor PG; Cowan E; Lyons MS; Richardson L; Rothman RE; Whiteside LK; Owens PH; Martel SH; Coupet E; Pantalon M; Curry L; Fiellin DA; Edelman EJ
    JAMA Netw Open; 2020 May; 3(5):e204561. PubMed ID: 32391893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergency Department Clinicians' Attitudes Toward Opioid Use Disorder and Emergency Department-initiated Buprenorphine Treatment: A Mixed-Methods Study.
    Im DD; Chary A; Condella AL; Vongsachang H; Carlson LC; Vogel L; Martin A; Kunzler N; Weiner SG; Samuels-Kalow M
    West J Emerg Med; 2020 Feb; 21(2):261-271. PubMed ID: 32191184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing waivered and non-waivered physician barriers to treating patients with substance use disorders: a cross-sectional Kentucky pilot.
    Thompson RA; Johnson D; Kizewski AL; Baier L; Coburn K; White J; Bunn T; Fletcher EL
    J Addict Dis; 2022; 40(4):518-526. PubMed ID: 35238283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary care physicians' preparedness to treat opioid use disorder in the United States: A cross-sectional survey.
    Foti K; Heyward J; Tajanlangit M; Meek K; Jones C; Kolodny A; Alexander GC
    Drug Alcohol Depend; 2021 Aug; 225():108811. PubMed ID: 34175786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of barriers to adoption of buprenorphine maintenance therapy by family physicians.
    DeFlavio JR; Rolin SA; Nordstrom BR; Kazal LA
    Rural Remote Health; 2015; 15():3019. PubMed ID: 25651434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Buprenorphine use and disparities in access among emergency department patients with opioid use disorder: A cross-sectional study.
    Robbins M; Haroz R; Mazzarelli A; Clements D; Jones CW; Salzman M
    J Subst Abuse Treat; 2021 Nov; 130():108405. PubMed ID: 34118697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Buprenorphine Prescribing Characteristics Following Relaxation of X-Waiver Training Requirements.
    Christine PJ; Chahine RA; Kimmel SD; Mack N; Douglas C; Stopka TJ; Calver K; Fanucchi LC; Slavova S; Lofwall M; Feaster DJ; Lyons M; Ezell J; Larochelle MR
    JAMA Netw Open; 2024 Aug; 7(8):e2425999. PubMed ID: 39102264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.